Dianthus Therapeutics (DNTH) Revenue (Gross) (2025)
Dianthus Therapeutics' quarterly Revenue (Gross) came in at $3.8 million in Q1 2025.
Dianthus Therapeutics has reported Revenue (Gross) for 1 years, with the latest figure at $3.8 million in Q1 2025.
- For the quarter ending Q1 2025, Revenue (Gross) changed N/A year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $3.8 million (changed N/A YoY), and the FY2024 full-year result was $17.4 million, up 264.5% from the prior year.
- Revenue (Gross) for Q1 2025 stood at $3.8 million.
- The five-year high for Revenue (Gross) was $3.8 million in Q1 2025, with the low at $3.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Gross) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.79 Mn |